Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.40 |
| ▸ | PTK2 | Q05397 | 8/20 | 0.39 |
| ▸ | FLT4 | P35916 | 2/20 | 0.34 |
| ▸ | CDC7 | O00311 | 1/20 | 0.34 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.34 |
| ▸ | TYRO3 | Q06418 | 5/20 | 0.34 |
| ▸ | MERTK | Q12866 | 5/20 | 0.34 |
| ▸ | AXL | P30530 | 4/20 | 0.34 |
| ▸ | WEE1 | P30291 | 2/20 | 0.34 |
| ▸ | PTK2B | Q14289 | 2/20 | 0.33 |
| ▸ | PKMYT1 | Q99640 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.33 |
| ▸ | BTK | Q06187 | 1/20 | 0.32 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.32 |
| ▸ | CDK4 | P11802 | 1/20 | 0.32 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.32 |
| ▸ | CCND1 | P24385 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | CCND3 | P30281 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30412210 | 1.00 | MAP4K1 (0.40) | MAP4K1PTK2FLT4CDC7DBF4 | |
| SCHEMBL25204192 | 0.90 | MAP4K1 (0.40) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL30412493 | 0.90 | MAP4K1 (0.40) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL30413194 | 0.89 | MAP4K1 (0.44) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL25208001 | 0.89 | MAP4K1 (0.44) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL25207999 | 0.89 | MAP4K1 (0.40) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL30412258 | 0.89 | MAP4K1 (0.40) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL26164228 | 0.88 | LRRK2 (0.37) | MAP4K1PTK2FLT4CDC7DBF4 | |
| SCHEMBL25220804 | 0.87 | MAP4K1 (0.38) | MAP4K1PTK2CDC7DBF4TYRO3 | |
| SCHEMBL30412783 | 0.87 | MAP4K1 (0.38) | MAP4K1PTK2CDC7DBF4TYRO3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. | 2025-05-08 | — | — | US | disclosed |
| WO-2023215494-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023215494-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. (US) | 2023-11-09 | — | — | WO | disclosed |
| WO-2023087027-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023087027-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ERASCA, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144094-A1 | THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF | ULK1, ULK2, ULK3 | MAP4K1 182/4885PTK2 1123/4885FLT4 2240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.